2022 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN | Döhner, Hartmut; Wei, Andrew H; Appelbaum, Frederick R; Craddock, Charles; DiNardo, Courtney D; Dombret, Hervé; Ebert, Benjamin L; Fenaux, Pierre; Godley, Lucy A; Hasserjian, Robert P; Larson, Richard A; Levine, Ross L; Miyazaki, Yasushi; Niederwieser, Dietger; Ossenkoppele, Gert; Röllig, Christoph; Sierra, Jorge; Stein, Eytan M; Tallman, Martin S; HWEI-FANG TIEN ; Wang, Jianxiang; Wierzbowska, Agnieszka; Löwenberg, Bob | Blood | 782 | 417 | |
2023 | Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial | Zeidan, Amer M; Ando, Kiyoshi; Rauzy, Odile; Turgut, Mehmet; Wang, Ming-Chung; Cairoli, Roberto; HSIN-AN HOU ; Kwong, Yok-Lam; Arnan, Montserrat; Meers, Stef; Pullarkat, Vinod; Santini, Valeria; Malek, Kamel; Kiertsman, Flavia; Niolat, Julie; Ramos, Pedro Marques; Menssen, Hans D; Fenaux, Pierre; Miyazaki, Yasushi; Platzbecker, Uwe | The Lancet. Haematology | 3 | 0 | |